Since the publication of the results of the CheckMate 816 trial (1), neoadjuvant chemoimmunotherapy has been introduced as a standard of care for stage IB-IIIA resectable NSCLC without mutations. The use of minimally invasive approaches...
This video illustrates a robotic assisted right apical S1 lung anatomical segmentectomy and radical lymphadenectomy for non-small cell lung cancer (NSCLC) performed with the DaVinci Xi surgical system. The video...